Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AKRO will rise by +0.94% over the next 2 Weeks and hit $55.17 by Tuesday, December 23, 2025. In that time frame, AKRO's share price is expected to range between $54.36 and $56.05.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Dec 23, 2025 | 54.29 | 55.05 | 55.84 |
| Dec 22, 2025 | 54.37 | 55.01 | 55.68 |
| Dec 19, 2025 | 54.40 | 54.94 | 55.49 |
| Dec 18, 2025 | 54.48 | 54.93 | 55.38 |
| Dec 17, 2025 | 54.58 | 54.93 | 55.29 |
| Dec 16, 2025 | 54.60 | 54.87 | 55.13 |
| Dec 15, 2025 | 54.63 | 54.83 | 55.02 |
| Dec 12, 2025 | 54.62 | 54.76 | 54.89 |
| Dec 11, 2025 | 54.66 | 54.75 | 54.84 |
| Dec 10, 2025 | 54.69 | 54.75 | 54.81 |
AKRO shares remained flat 0 in Tuesday, December 9, 2025's trading session, starting and closing at a previous close of $54.65 to move at $54.65. The stock demonstrated notable intraday movement (see AKRO's key stats for a full breakdown), fluctuating between $54.52 and $54.65, a +0.24% trading range. While recent weeks have seen some volatility, AKRO has managed to secure a +0.53% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 11.61M shares changing hands, 3.38M fewer than the previous session. This amounted to $634.44M in total market activity.
Will AKRO Continue Its Upward Trend?
According to analyst ratings and projections for AKRO, Akero Therapeutics, Inc. shares are anticipated to increase by +2.13%, potentially reaching $55.84 per share by December 23, 2025. Short-term technical indicators currently suggest a neutral sentiment for AKRO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the AKRO stock forecast, now is a good time to buy AKRO stock because its current trading price is -0.73% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AKRO covering social and institutional perspectives.
AKRO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AKRO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 65.56% to 70.51%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 56.94%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.75%, maintains a neutral outlook for the long term. Insights into AKRO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Akero Therapeutics Short-Term Forecasts
AKRO Forecast For Next 5 Days
Our algorithm anticipates Akero Therapeutics (AKRO) stock could hit $54.63 by Jan 02, 2026. This represents a -0.04% rise from today's price, following a +0.29% change over the past five days.
AKRO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Akero Therapeutics, Inc. (AKRO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $54.17, which would mean a -0.88% decrease from the current price of $54.65. Projections for this period range from a high of $57.99 to a low of $50.59.
AKRO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Akero Therapeutics's price over the next three months point to a drop. AKRO stock is expected to peak at $48.68 on Mar 19, 2026 after potentially dipping to $33.47 on Feb 12, 2026. On average, AKRO is likely to trade around $40.15 in the coming 90 days.
Akero Therapeutics Stock Forecast 2025
Based on our predictive models, Akero Therapeutics (AKRO) is expected to trade between $33.18 and $52.14 throughout 2026. This would result in an average price of $40.74, potentially offering investors a -25.45% return from current levels.
Akero Therapeutics, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Akero Therapeutics, Inc. (AKRO) is positioned to show a strong performance in December 2025. The price is predicted to move between $33.52 and $44.40, settling at an average of $39.00. This could translate to a -28.64% loss.
January 2026
Based on current market signals, Akero Therapeutics, Inc. is projected to trend january 2026. We forecast a trading range from $33.18 to $45.49, with a likely average price of $39.23. Investors could expect a potential return of -28.22%.
February 2026
Our predictive algorithms indicate Akero Therapeutics, Inc. stock may see a shift in February 2026. The expected range spans $33.47–$45.67, with an average target of $39.16. This represents a cautious outlook and a possible loss of -28.34%.
March 2026
Analyzing established trends, Akero Therapeutics, Inc. looks set to move in March 2026. Projections place the stock between $35.22 and $48.68, averaging around $41.92. This suggests a -23.29% loss from current levels.
April 2026
Market indicators suggest Akero Therapeutics, Inc. could experience notable changes during April 2026. Prices could fluctuate within $33.43 to $49.89, with a midpoint forecast of $40.75. The stock might deliver a -25.43% loss.
May 2026
Forecasting for May 2026, models estimate that Akero Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $34.35 and $48.29, averaging $40.82. This signals a cautious trajectory with potential returns around -25.31%.
June 2026
According to our latest forecast models, Akero Therapeutics, Inc. (AKRO) is positioned to show a strong performance in June 2026. The price is predicted to move between $33.48 and $46.05, settling at an average of $39.88. This could translate to a -27.03% loss.
July 2026
Based on current market signals, Akero Therapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $34.12 to $45.58, with a likely average price of $40.01. Investors could expect a potential return of -26.79%.
August 2026
Our predictive algorithms indicate Akero Therapeutics, Inc. stock may see a shift in August 2026. The expected range spans $34.91–$49.06, with an average target of $42.50. This represents a cautious outlook and a possible loss of -22.23%.
September 2026
Analyzing established trends, Akero Therapeutics, Inc. looks set to move in September 2026. Projections place the stock between $34.28 and $50.13, averaging around $41.74. This suggests a -23.62% loss from current levels.
October 2026
Market indicators suggest Akero Therapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $34.85 to $50.96, with a midpoint forecast of $41.29. The stock might deliver a -24.45% loss.
November 2026
Forecasting for November 2026, models estimate that Akero Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $34.61 and $52.14, averaging $40.92. This signals a cautious trajectory with potential returns around -25.12%.
December 2026
According to our latest forecast models, Akero Therapeutics, Inc. (AKRO) is positioned to show a strong performance in December 2026. The price is predicted to move between $35.46 and $45.99, settling at an average of $40.29. This could translate to a -26.28% loss.
AKRO's history of dividends and stock splits also plays a role in long-term investor confidence.

